1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow TCC1727 tablet 90mg: new trials by email Literature Review of TCC1727 tablet 90mg trials Research Report on TCC1727 tablet 90mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg - Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 1 / Phase 2 | Recruiting | Beijing Tide Pharmaceutical Co., Ltd | 266 | 2025-12-03 | 2026-01-28 |
Ataxia Telangiectasia (1) · Carcinoma, Non-Small-Cell Lung (1) · Endometrial Neoplasms (1) · Melanoma (1) · Stomach Neoplasms (1)
Beijing Tide Pharmaceutical Co., Ltd (1)
China (1)